Patent Leaderboard
USPTO Patent Rankings Data through Dec 31, 2025
Home › Dipeptidylpeptidase 4 inhibition enhances lymphocyte trafficking, improving both naturally occurring tumor immunity and immunotherapy

Dipeptidylpeptidase 4 inhibition enhances lymphocyte trafficking, improving both naturally occurring tumor immunity and immunotherapy

US Patent 11229645 · Granted Jan 25, 2022

Assignee

Inventors

View full patent text on Google Patents →

More Patents by These Inventors

Diagnostic and therapeutic methods for cancer2024
Dipeptidylpeptidase 4 inhibition enhances lymphocyte trafficking, improving both2024
Dipeptidylpeptidase 4 inhibition enhances lymphocyte trafficking, improving both2024
Anti-CD8 antibodies and uses thereof2023
Dipeptidylpeptidase 4 inhibition enhances lymphocyte trafficking, improving both2021
Dipeptidylpeptidase 4 inhibition enhances lymphocyte trafficking, improving both2021
Levels of CXCL10/IP-10 forms and soluble CD26/DPPIV activity as early predictive2019
Levels of CXCL 10/IP-10 forms and soluble CD26/DPPIV activity as early predictiv2016
Methods of using sIP-10, CD26 inhibitors and CXCR3 levels in a sample to assess 2012
Methods for use of apoptotic cells to deliver antigen to dendritic cells for ind2011
Methods of using sIP-10 to assess HCV clearance and/or response to interferon th2010
Methods for use of apoptotic cells to deliver antigen to dendritic cells for ind2006